Stoic Venture Capital

Stoic Venture Capital is a venture capital firm investing in early-stage technology companies emerging from Australian and New Zealand universities. They focus on commercializing university research, particularly in human health, advanced computing, and environmental technologies. Their investment range is between $100,000 and $1 million, targeting seed and Series A stages. Stoic VC partners with Uniseed, Australia's most experienced university commercialization fund, to access a proprietary pipeline of world-class science. Their portfolio includes companies like Kinoxis, Neurode, and BioScout, reflecting their commitment to transforming research into commercially viable products. Stoic VC's multidisciplinary team brings decades of experience in building, scaling, and fundraising, with a deep network ready to support founders from lab to market. They aim to solve the planet's most intractable problems by investing in breakthrough science and engineering emerging from top Australian research institutions.